- Home
- WU vs PRCT Comparison
WU vs PRCT Comparison
Compare WU & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WU
- PRCT
- Stock Information
- Founded
- WU 1851
- PRCT 2009
- Country
- WU United States
- PRCT United States
- Employees
- WU N/A
- PRCT N/A
- Industry
- WU Business Services
- PRCT Medical Specialities
- Sector
- WU Consumer Discretionary
- PRCT Health Care
- Exchange
- WU Nasdaq
- PRCT Nasdaq
- Market Cap
- WU 2.6B
- PRCT 2.1B
- IPO Year
- WU 2006
- PRCT 2021
- Fundamental
- Price
- WU $8.19
- PRCT $34.63
- Analyst Decision
- WU Hold
- PRCT Buy
- Analyst Count
- WU 10
- PRCT 8
- Target Price
- WU $8.56
- PRCT $70.00
- AVG Volume (30 Days)
- WU 11.5M
- PRCT 1.0M
- Earning Date
- WU 10-22-2025
- PRCT 10-27-2025
- Dividend Yield
- WU 11.51%
- PRCT N/A
- EPS Growth
- WU 61.96
- PRCT N/A
- EPS
- WU 2.65
- PRCT N/A
- Revenue
- WU $4,103,899,999.00
- PRCT $274,950,000.00
- Revenue This Year
- WU $0.22
- PRCT $48.38
- Revenue Next Year
- WU $0.66
- PRCT $30.87
- P/E Ratio
- WU $3.08
- PRCT N/A
- Revenue Growth
- WU N/A
- PRCT 55.71
- 52 Week Low
- WU $7.85
- PRCT $34.01
- 52 Week High
- WU $12.02
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- WU 49.11
- PRCT 36.50
- Support Level
- WU $7.96
- PRCT $34.01
- Resistance Level
- WU $8.20
- PRCT $36.48
- Average True Range (ATR)
- WU 0.16
- PRCT 1.58
- MACD
- WU 0.01
- PRCT 0.00
- Stochastic Oscillator
- WU 68.14
- PRCT 9.20
About WU Western Union Company (The)
Western Union provides domestic and international money transfers through its global network of over 500,000 outside agents. The company handled almost 290 million transactions in 2024 and is the largest money transfer company in the world.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.